Opiant Pharmaceuticals, Inc

(NASDAQ:OPNT)

Latest On Opiant Pharmaceuticals, Inc (OPNT):

Date/Time Type Description Signal Details
2023-02-11 06:12 ESTNewsWhat's The Opiant CVR Worth?N/A
2023-01-26 23:40 ESTNewsHorizon Pharma, Opiant fall amid Elizabeth Warren concern about pharma deals (update)N/A
2023-01-20 08:58 ESTNewsOpiant wins FDA priority review for opioid overdose therapyN/A
2023-01-14 01:31 ESTNewsOpiant Pharmaceuticals: Nano-Cap Buyout With Interesting CVR Thrown InN/A
2022-11-14 13:17 ESTNewsOpiant Pharmaceuticals GAAP EPS of -$1.93 misses by $0.42, revenue of $0.2M misses by $3.48MN/A
2022-11-14 13:17 ESTNewsOpiant surges 123% as Indivior set to acquire overdose therapy maker for $145MN/A
2022-08-12 23:26 ESTNewsOpiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-12 06:20 ESTNewsOpiant Pharmaceuticals GAAP EPS of -$2.31 misses by $0.95, revenue of $3.89M misses by $0.77MN/A
2022-08-10 21:44 ESTNewsOpiant Pharmaceuticals Q2 Earnings PreviewN/A
2022-08-09 06:22 ESTNewsOpiant awarded additional $2.1M from BARDA for its nasal opioid overdose treatmentN/A
2022-06-08 23:09 ESTNewsOpiant, Aptar expand collaboration for the making of Unidose nasal spray for OPNT003N/A
2022-05-14 20:56 ESTNewsOpiant Pharmaceuticals, Inc. (OPNT) CEO Dr. Roger Crystal on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-11 07:38 ESTNewsOpiant Pharmaceuticals GAAP EPS of -$2.43 misses by $1.68, revenue of $4.47M misses by $1.43MN/A
2022-05-10 11:36 ESTNewsOpiant Pharmaceuticals Q1 Earnings PreviewN/A
2022-04-30 05:09 ESTNewsOpiant denies licensing deal for opioid overdose therapyN/A
2022-04-28 17:37 ESTNewsOpiant opioid overdose candidate namalfene demonstrates non-inferiority to naloxoneN/A
2022-04-28 02:06 ESTNewsOpiant says pharmacodynamic study shows benefit of its opioid overdose treatment OPNT003N/A
2022-03-22 00:17 ESTNewsOpiant Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-16 08:15 ESTNewsOpiant Pharmaceuticals GAAP EPS of $0.11 beats by $0.01, revenue of $13.8M beats by $0.54MN/A
2022-03-16 08:14 ESTNewsOpiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal On Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-15 07:39 ESTNewsOpiant Pharmaceuticals Q4 Earnings PreviewN/A
2022-02-08 22:39 ESTNewsOpiant Pharmaceuticals briefly spikes on takeover speculationN/A
2022-01-25 00:46 ESTNewsOpiant to get additional $2.2M from BARDA for OPNT003 to treat opioid overdoseN/A
2021-11-12 06:27 ESTNewsOpiant Pharmaceuticals EPS beats by $0.35, beats on revenueN/A
2021-11-12 06:27 ESTNewsOpiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-11 11:02 ESTNewsOpiant Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-11-05 11:25 ESTNewsOpiant gets FDA fast track status for OPNT003 for treatment of opioid overdoseN/A
2021-09-22 02:58 ESTNewsOpiant Pharmaceuticals: Assessing Recent Insider BuyingN/A
2021-08-07 23:01 ESTNewsOpiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-06 08:28 ESTNewsOpiant Pharmaceuticals EPS beats by $0.59, beats on revenueN/A
2021-07-21 18:46 ESTNewsOpiant shares soar 35% on OPNT003 opioid overdose study resultsN/A
2021-04-06 07:19 ESTNewsOpiant Pharmaceuticals starts dosing in OPNT003 studyN/A
2021-04-01 02:05 ESTNewsOpiant Pharmaceuticals awarded final tranche of NIDA grantN/A
2021-03-08 00:14 ESTEarnings EstimateAn EPS average of -$0.70 is estimated for the quarter ending on March 31, 2021.Sell
2021-03-08 00:14 ESTEarnings EstimateAn EPS average of $0.82 is estimated for the 2022 year.Buy
2021-03-08 00:14 ESTEarnings EstimateAn EPS average of -$0.32 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-07 08:18 ESTFinancialsCompany financials have been released.Neutral
2021-03-05 03:00 ESTNewsOpiant Pharmaceuticals EPS misses by $0.23, beats on revenueN/A
2021-03-05 02:59 ESTNewsOpiant Pharmaceuticals' (OPNT) CEO Roger Crystal on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-10 16:32 ESTNewsOpiant's confirmatory pharmacokinetic study of OPNT003 gets underwayN/A
2020-12-14 23:14 ESTNewsOpiant Pharma secures additional BARDA grant of $3.5M for OPNT003N/A
2020-12-10 16:33 ESTNewsOpiant Pharmaceuticals receives $50M in convertible debt financingN/A
2020-11-26 21:06 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 13:06 ESTAnalyst RatingThe Analyst Target Price has increased from $40 to $41.33.Buy
2020-11-17 12:29 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 06:17 ESTNewsOpiant Pharmaceuticals EPS beats by $0.36, beats on revenueN/A
2020-11-13 06:17 ESTNewsOpiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-08 00:27 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:44 ESTFinancialsCompany financials have been released.Neutral
2020-11-03 12:27 ESTFinancialsCompany financials have been released.Neutral

About Opiant Pharmaceuticals, Inc (OPNT):

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.

OPNT Quotes by TradingView

See Advanced Chart

General

  • Name Opiant Pharmaceuticals, Inc
  • Symbol OPNT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 30
  • Last Split Factor1:100
  • Last Split Date2014-12-31
  • Fiscal Year EndJuly
  • IPO Date2016-01-04
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.opiant.com
View More

Valuation

  • Trailing PE 4.43
  • Forward PE 26.74
  • Price/Sales (Trailing 12 Mt.) 1.74
  • Price/Book (Most Recent Quarter) 1.46
  • Enterprise Value Revenue 0.76
  • Enterprise Value EBITDA 0.33
View More

Financials

  • Most Recent Quarter 2020-10-31
  • Profit Margin -6%
  • Operating Margin -8%
  • Return on Assets -3%
  • Return on Equity -5%
  • Revenue 29.63 million
  • Earnings Per Share $1.79
  • Revenue Per Share $6.97
  • Gross Profit 14.19 million
  • Quarterly Earnings Growth 29.4%
View More

Highlights

  • Market Capitalization 47.04 million
  • EBITDA 9.49 million
  • Analyst Target Price $41.33
  • Book Value Per Share $8.34
View More

Share Statistics

  • Shares Outstanding 4.29 million
  • Shares Float 3.87 million
  • % Held by Insiders 567%
  • % Held by Institutions 31.07%
  • Shares Short 10798
  • Shares Short Prior Month 10123
  • Short Ratio 0.18
View More

Technicals

  • Beta 0.8
  • 52 Week High $14.98
  • 52 Week Low $6.79
  • 50 Day Moving Average 12.64
  • 200 Day Moving Average 9.29
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Opiant Pharmaceuticals, Inc (OPNT) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Opiant Pharmaceuticals, Inc (OPNT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2021-01-312021-03-04-$0.16$0.07-318.28%
2020-10-312020-11-12$N/A$0.15-$0.21172.57%
2020-07-312020-08-06$N/A-$0.05-$0.2479.45%
2020-04-302020-05-12$N/A-$0.40-$0.19-106.93%
2020-01-312020-03-04$N/A$0.20$0.1811.11%
2019-10-312019-11-12$N/A$1.97-$0.131615.38%
2019-07-312019-08-08$N/A$0.31-$0.55156.03%
2019-04-302019-05-09$N/A-$0.44-$0.7944.3%
2019-01-312019-03-21$5.44 million-$0.37-$0.13-184.62%
2018-10-312018-11-07$4.76 million-$0.32-$0.26-25.49%
2018-07-312018-08-09$4.37 million-$0.52-$1.1755.36%
2018-04-302018-05-08$3.15 million-$3.68-$0.29-1168.97%
2018-01-312018-03-07$1.7 million-$3.68
2017-07-312017-10-13$3.77 million-$0.17-$0.8780.46%
2017-04-302017-06-14$18000-$1.55-$0.82-89.02%
2017-01-312017-03-15$13.54 million$4.91-$0.85677.65%
2016-10-312016-12-15$1.12 million-$0.30-$1.1774.36%
2016-07-312016-10-28$313000-$0.52-$1.5265.79%
2016-04-302016-06-08$2.61 million$0.15
2016-01-312016-03-15$6.86 million$1.52
2015-10-312015-12-14$120000-$6.00
2015-07-312015-10-26$870000-$0.41
2015-04-302015-04-30$120000-$1.01
2015-01-312015-01-31$560000-$1.54
2014-10-312014-10-31$N/A-$0.43
2014-07-312014-07-31$N/A-$2.33
2014-04-302014-04-30$N/A-$0.31
2014-01-312014-01-31$N/A-$2.96
2013-10-312013-10-31$N/A-$1.03
2013-07-312013-07-31$N/A-$1.34
2013-04-302013-04-30$N/A-$0.83
2013-01-312013-01-31$N/A-$0.43
2012-10-312012-10-31$N/A-$0.65
2012-07-312012-07-31$N/A-$1.60
2012-04-302012-04-30$N/A-$1.15
2012-01-312012-01-31$N/A-$3.91
2011-10-312011-10-31$N/A-$4.42
2011-07-312011-07-31$N/A-$3.47
2011-04-302011-04-30$N/A-$7.28
2011-01-312011-01-31$N/A-$1.47
2010-10-312010-10-31$N/A-$0.46
2010-07-312010-07-31$N/A-$0.56
2010-04-302010-04-30$N/A-$0.23
2010-01-312010-01-31$N/A-$1.09

Opiant Pharmaceuticals, Inc (OPNT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Opiant Pharmaceuticals, Inc (OPNT) Chart:

Opiant Pharmaceuticals, Inc (OPNT) News:

Below you will find a list of latest news for Opiant Pharmaceuticals, Inc (OPNT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Opiant Pharmaceuticals, Inc (OPNT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest OPNT Trades:

Date Shares Price
Jun 13, 2022 7:38 PM EST31$11.01
Jun 13, 2022 7:41 PM EST1$11.14
Jun 13, 2022 7:58 PM EST5$11.08
Jun 13, 2022 7:59 PM EST100$10.91
Jun 13, 2022 7:59 PM EST5$10.88

Opiant Pharmaceuticals, Inc (OPNT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000083/0001385508-20-000083-index.htm
2012-11-29UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1108924/000000000012064464/0000000000-12-064464-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1385508/000092189520000507/0000921895-20-000507-index.htm
2013-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1108924/000093247113002597/0000932471-13-002597-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1385508/000093583620000117/0000935836-20-000117-index.htm
2012-12-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1108924/000114420412069987/0001144204-12-069987-index.htm
2012-12-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1108924/000114420412069989/0001144204-12-069989-index.htm
2012-12-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000118143112065624/0001181431-12-065624-index.htm
2012-12-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000118143112065632/0001181431-12-065632-index.htm
2012-12-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000118143112065639/0001181431-12-065639-index.htm
2012-12-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000118143112065641/0001181431-12-065641-index.htm
2012-07-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512318806/0001193125-12-318806-index.htm
2012-07-27DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1108924/000119312512318814/0001193125-12-318814-index.htm
2012-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1108924/000119312512340861/0001193125-12-340861-index.htm
2012-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1108924/000119312512341441/0001193125-12-341441-index.htm
2012-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1108924/000119312512389599/0001193125-12-389599-index.htm
2012-10-29425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512439884/0001193125-12-439884-index.htm
2012-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1108924/000119312512439899/0001193125-12-439899-index.htm
2012-10-29425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512439900/0001193125-12-439900-index.htm
2012-10-29425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512439917/0001193125-12-439917-index.htm
2012-10-29425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512439919/0001193125-12-439919-index.htm
2012-10-29425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512439925/0001193125-12-439925-index.htm
2012-10-29425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512439928/0001193125-12-439928-index.htm
2012-10-29425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512439931/0001193125-12-439931-index.htm
2012-10-29425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512439937/0001193125-12-439937-index.htm
2012-10-29425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512439941/0001193125-12-439941-index.htm
2012-10-29425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512439952/0001193125-12-439952-index.htm
2012-10-30425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512441512/0001193125-12-441512-index.htm
2012-10-31425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512443746/0001193125-12-443746-index.htm
2012-11-01425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512444491/0001193125-12-444491-index.htm
2012-11-02425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512447178/0001193125-12-447178-index.htm
2012-11-02425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512447293/0001193125-12-447293-index.htm
2012-11-02425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512449032/0001193125-12-449032-index.htm
2012-11-06SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1108924/000119312512454885/0001193125-12-454885-index.htm
2012-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1108924/000119312512457833/0001193125-12-457833-index.htm
2012-11-14SC TO-TTender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1108924/000119312512468850/0001193125-12-468850-index.htm
2012-11-14SC 14D9Solicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512468890/0001193125-12-468890-index.htm
2012-11-15SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1108924/000119312512471191/0001193125-12-471191-index.htm
2012-11-16425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512473067/0001193125-12-473067-index.htm
2012-11-16SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1108924/000119312512473209/0001193125-12-473209-index.htm
2012-11-21SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512478990/0001193125-12-478990-index.htm
2012-11-28SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1108924/000119312512483787/0001193125-12-483787-index.htm
2012-11-29425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512484651/0001193125-12-484651-index.htm
2012-11-29425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512484656/0001193125-12-484656-index.htm
2012-11-29SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1108924/000119312512484658/0001193125-12-484658-index.htm
2012-12-03SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512487961/0001193125-12-487961-index.htm
2012-12-03SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1108924/000119312512488218/0001193125-12-488218-index.htm
2012-12-03SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512489282/0001193125-12-489282-index.htm
2012-12-05425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512491048/0001193125-12-491048-index.htm
2012-12-05SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1108924/000119312512491054/0001193125-12-491054-index.htm
2012-12-05SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512491254/0001193125-12-491254-index.htm
2012-12-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1108924/000119312512491261/0001193125-12-491261-index.htm
2012-12-07SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1108924/000119312512495329/0001193125-12-495329-index.htm
2012-12-18SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1108924/000119312512505612/0001193125-12-505612-index.htm
2012-12-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1108924/000119312512506624/0001193125-12-506624-index.htm
2012-12-18S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512506683/0001193125-12-506683-index.htm
2012-12-18S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512506690/0001193125-12-506690-index.htm
2012-12-18S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512506694/0001193125-12-506694-index.htm
2012-12-18S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512506703/0001193125-12-506703-index.htm
2012-12-18S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512506710/0001193125-12-506710-index.htm
2012-12-19SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1108924/000119312512506975/0001193125-12-506975-index.htm
2012-12-21SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1108924/000119312512510792/0001193125-12-510792-index.htm
2012-12-3115-12GSecurities registration termination [Section 12(g)]https://www.sec.gov/Archives/edgar/data/1108924/000119312512518791/0001193125-12-518791-index.htm
2012-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000120919112058759/0001209191-12-058759-index.htm
2012-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000120919112058760/0001209191-12-058760-index.htm
2012-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000120919112058761/0001209191-12-058761-index.htm
2012-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000120919112058762/0001209191-12-058762-index.htm
2012-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000120919112058763/0001209191-12-058763-index.htm
2012-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000120919112058920/0001209191-12-058920-index.htm
2012-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000124266512000010/0001242665-12-000010-index.htm
2012-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000124266512000011/0001242665-12-000011-index.htm
2012-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000124266512000012/0001242665-12-000012-index.htm
2012-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000124266512000013/0001242665-12-000013-index.htm
2012-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000124266512000014/0001242665-12-000014-index.htm
2012-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000124266512000015/0001242665-12-000015-index.htm
2012-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000124266512000016/0001242665-12-000016-index.htm
2012-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000124266512000017/0001242665-12-000017-index.htm
2012-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000124266512000018/0001242665-12-000018-index.htm
2012-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1108924/000124266512000019/0001242665-12-000019-index.htm
2012-12-1925-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or rethttps://www.sec.gov/Archives/edgar/data/1108924/000135445712000286/0001354457-12-000286-index.htm
2019-09-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550819000095/0001385508-19-000095-index.htm
2019-09-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550819000096/0001385508-19-000096-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550819000098/0001385508-19-000098-index.htm
2019-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550819000100/0001385508-19-000100-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550819000107/0001385508-19-000107-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1385508/000138550819000109/0001385508-19-000109-index.htm
2019-11-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1385508/000138550819000113/0001385508-19-000113-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550819000114/0001385508-19-000114-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550819000117/0001385508-19-000117-index.htm
2019-11-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550819000119/0001385508-19-000119-index.htm
2019-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550819000121/0001385508-19-000121-index.htm
2019-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550819000123/0001385508-19-000123-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550819000125/0001385508-19-000125-index.htm
2019-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550819000127/0001385508-19-000127-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000002/0001385508-20-000002-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000006/0001385508-20-000006-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000009/0001385508-20-000009-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000011/0001385508-20-000011-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000013/0001385508-20-000013-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000015/0001385508-20-000015-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000017/0001385508-20-000017-index.htm
2020-01-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000019/0001385508-20-000019-index.htm
2020-02-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000022/0001385508-20-000022-index.htm
2020-02-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000023/0001385508-20-000023-index.htm
2020-02-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000025/0001385508-20-000025-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000030/0001385508-20-000030-index.htm
2020-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000037/0001385508-20-000037-index.htm
2020-03-0410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1385508/000138550820000039/0001385508-20-000039-index.htm
2020-03-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000041/0001385508-20-000041-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000044/0001385508-20-000044-index.htm
2020-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000046/0001385508-20-000046-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000048/0001385508-20-000048-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000056/0001385508-20-000056-index.htm
2020-05-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1385508/000138550820000057/0001385508-20-000057-index.htm
2020-05-21DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000059/0001385508-20-000059-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000061/0001385508-20-000061-index.htm
2020-06-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000063/0001385508-20-000063-index.htm
2020-06-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000065/0001385508-20-000065-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000067/0001385508-20-000067-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000069/0001385508-20-000069-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000071/0001385508-20-000071-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000073/0001385508-20-000073-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000075/0001385508-20-000075-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000077/0001385508-20-000077-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000079/0001385508-20-000079-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000081/0001385508-20-000081-index.htm
2020-06-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000083/0001385508-20-000083-index.htm
2020-07-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000085/0001385508-20-000085-index.htm
2020-07-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000087/0001385508-20-000087-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000093/0001385508-20-000093-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1385508/000138550820000094/0001385508-20-000094-index.htm
2020-09-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000096/0001385508-20-000096-index.htm
2020-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1385508/000138550820000100/0001385508-20-000100-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1385508/000138713120001748/0001387131-20-001748-index.htm
2012-07-27ARSAnnual Report to Security Holdershttps://www.sec.gov/Archives/edgar/data/1108924/999999999712012355/9999999997-12-012355-index.htm

Opiant Pharmaceuticals, Inc (OPNT) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Opiant Pharmaceuticals, Inc (OPNT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 567%
Institutional Ownership: 3107%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2012-12-18ALAIN J COHENPresident & Chief Tech OfficerSell1,399.0041.7858,450.220.00https://www.sec.gov/Archives/edgar/data/1108924/000120919112058760/0001209191-12-058760-index.htm
2012-12-18MARC A COHENChairman, CEO, Treas & SecySell5,290.0041.78221,016.200.00https://www.sec.gov/Archives/edgar/data/1108924/000120919112058761/0001209191-12-058761-index.htm
2012-12-18Melvin III WesleyChief Financial OfficerSell24,516.0041.781,024,278.480.00https://www.sec.gov/Archives/edgar/data/1108924/000120919112058763/0001209191-12-058763-index.htm
2019-10-03Phil SkolnickChief Scientific OfficerSell1,609.0014.2722,960.430.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000098/0001385508-19-000098-index.htm
2019-11-05Phil SkolnickChief Scientific OfficerSell2,500.0014.8937,225.000.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000100/0001385508-19-000100-index.htm
2019-12-06Phil SkolnickChief Scientific OfficerSell800.0013.3410,672.000.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000125/0001385508-19-000125-index.htm
2012-12-18RONALD W KAISERDirectorSell3,000.0041.78125,340.000.00https://www.sec.gov/Archives/edgar/data/1108924/000120919112058920/0001209191-12-058920-index.htm
2012-12-18STEVEN G FINNDirectorSell3,000.0041.78125,340.000.00https://www.sec.gov/Archives/edgar/data/1108924/000120919112058759/0001209191-12-058759-index.htm
2012-12-18WILLIAM F STASIORDirectorSell3,000.0041.78125,340.000.00https://www.sec.gov/Archives/edgar/data/1108924/000120919112058762/0001209191-12-058762-index.htm
2019-12-12Ann L. MacDougallDirectorBuy5,000.0014.5472,700.0010,000.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000127/0001385508-19-000127-index.htm
2019-10-01Phil SkolnickChief Scientific OfficerBuy10,000.009.0090,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000098/0001385508-19-000098-index.htm
2019-11-01Phil SkolnickChief Scientific OfficerBuy10,000.009.0090,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000100/0001385508-19-000100-index.htm
2019-12-02Phil SkolnickChief Scientific OfficerBuy10,000.009.0090,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000123/0001385508-19-000123-index.htm
2020-01-02Phil SkolnickChief Scientific OfficerBuy10,000.009.0090,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000002/0001385508-20-000002-index.htm
2020-01-07Phil SkolnickChief Scientific OfficerBuy4,150.0010,035.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000015/0001385508-20-000015-index.htm
2012-11-01STEVEN G FINNDirectorBuy15,000.0015.42231,300.00106,000.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000016/0001242665-12-000016-index.htm
2012-09-04WILLIAM F STASIORDirectorBuy10,000.008.6186,100.00110,000.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000012/0001242665-12-000012-index.htm
2012-09-10WILLIAM F STASIORDirectorBuy3,000.00113,000.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000014/0001242665-12-000014-index.htm
2012-11-01STEVEN G FINNDirectorBuy10,000.0013.25132,500.00116,000.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000016/0001242665-12-000016-index.htm
2020-06-15Ann L. MacDougallDirectorBuy2,000.0012,000.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000073/0001385508-20-000073-index.htm
2012-11-06WILLIAM F STASIORDirectorBuy15,000.0015.42231,300.00128,000.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000018/0001242665-12-000018-index.htm
2020-01-07David D O'TooleChief Financial OfficerBuy4,150.0013,365.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000017/0001385508-20-000017-index.htm
2012-11-06WILLIAM F STASIORDirectorBuy10,000.0013.25132,500.00138,000.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000018/0001242665-12-000018-index.htm
2020-05-26David D O'TooleChief Financial OfficerBuy1,000.0011.0011,000.0014,365.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000061/0001385508-20-000061-index.htm
2020-06-11David D O'TooleChief Financial OfficerBuy1,000.008.748,740.0015,365.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000067/0001385508-20-000067-index.htm
2019-10-02Phil SkolnickChief Scientific OfficerSell1,102.0014.5716,056.141,609.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000098/0001385508-19-000098-index.htm
2019-11-22Gabrielle Alison SilverDirectorBuy1,785.0013.5124,115.351,785.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000119/0001385508-19-000119-index.htm
2019-09-12Richard J DalyDirectorBuy1,800.0013.9025,020.001,800.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000030/0001385508-20-000030-index.htm
2020-06-15Craig A CollardDirectorBuy2,000.002,000.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000071/0001385508-20-000071-index.htm
2020-06-15Thomas T. ThomasDirectorBuy2,000.002,000.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000075/0001385508-20-000075-index.htm
2020-01-07ROGER CRYSTALChief Executive OfficerBuy13,650.0022,125.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000011/0001385508-20-000011-index.htm
2019-11-04Phil SkolnickChief Scientific OfficerSell299.0015.284,568.722,500.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000100/0001385508-19-000100-index.htm
2019-10-01Phil SkolnickChief Scientific OfficerSell7,289.0014.79107,804.312,711.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000098/0001385508-19-000098-index.htm
2012-06-13MARC A COHENChairman,CEO,Treas, & SecSell12,000.0024.32291,840.002,718,222.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000011/0001242665-12-000011-index.htm
2012-06-13MARC A COHENChairman,CEO,Treas, & SecBuy12,000.005.8570,200.002,730,222.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000011/0001242665-12-000011-index.htm
2012-06-14MARC A COHENChairman,CEO,Treas, & SecSell12,323.0024.68304,131.642,743,899.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000011/0001242665-12-000011-index.htm
2012-06-14MARC A COHENChairman,CEO,Treas, & SecBuy38,000.005.85222,300.002,756,222.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000011/0001242665-12-000011-index.htm
2012-11-14MARC A COHENChairman,CEO,Treas, & SecBuy48,000.0011.75564,000.002,791,899.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000019/0001242665-12-000019-index.htm
2019-11-01Phil SkolnickChief Scientific OfficerSell7,201.0015.10108,735.102,799.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000100/0001385508-19-000100-index.htm
2019-12-03Phil SkolnickChief Scientific OfficerSell4,578.0013.9363,771.542,857.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000123/0001385508-19-000123-index.htm
2012-10-29Melvin III WesleyChief Financial OfficerBuy13,333.009.79130,530.0733,259.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000017/0001242665-12-000017-index.htm
2020-06-15Richard J DalyDirectorBuy2,000.003,800.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000079/0001385508-20-000079-index.htm
2012-06-06RONALD W KAISERDirectorSell10,000.0026.04260,400.0040,000.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000010/0001242665-12-000010-index.htm
2020-01-07Phil SkolnickChief Scientific OfficerSell3,043.0013.3640,654.484,150.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000015/0001385508-20-000015-index.htm
2012-09-10RONALD W KAISERDirectorBuy3,000.0043,000.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000015/0001242665-12-000015-index.htm
2020-09-03Thomas T. ThomasDirectorBuy2,500.008.4021,000.004,500.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000096/0001385508-20-000096-index.htm
2020-06-10Gabrielle Alison SilverDirectorBuy2,730.009.1324,924.904,515.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000069/0001385508-20-000069-index.htm
2012-12-18Melvin III WesleyChief Financial OfficerBuy26,667.009.79261,069.9346,295.00https://www.sec.gov/Archives/edgar/data/1108924/000120919112058763/0001209191-12-058763-index.htm
2020-09-04Thomas T. ThomasDirectorBuy500.008.054,025.005,000.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000096/0001385508-20-000096-index.htm
2012-06-06RONALD W KAISERDirectorBuy10,000.0013.25132,500.0050,000.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000010/0001242665-12-000010-index.htm
2020-01-07Phil SkolnickChief Scientific OfficerSell2,900.0013.6039,440.005,885.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000015/0001385508-20-000015-index.htm
2020-06-15Gabrielle Alison SilverDirectorBuy2,000.006,515.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000077/0001385508-20-000077-index.htm
2020-06-15Sinclair MichaelDirectorBuy2,000.0071,220.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000081/0001385508-20-000081-index.htm
2020-01-08Phil SkolnickChief Scientific OfficerSell2,842.0013.4638,253.327,193.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000015/0001385508-20-000015-index.htm
2019-12-02Phil SkolnickChief Scientific OfficerSell2,565.0014.1736,346.057,435.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000123/0001385508-19-000123-index.htm
2019-12-05Phil SkolnickChief Scientific OfficerSell2,057.0013.7428,263.18800.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000125/0001385508-19-000125-index.htm
2020-01-06Phil SkolnickChief Scientific OfficerSell515.0013.807,107.008,785.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000002/0001385508-20-000002-index.htm
2012-09-10STEVEN G FINNDirectorBuy10,000.008.6186,100.0088,000.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000013/0001242665-12-000013-index.htm
2019-11-15David D O'TooleChief Financial OfficerBuy1,000.0014.9114,910.009,015.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000117/0001385508-19-000117-index.htm
2012-09-10STEVEN G FINNDirectorBuy3,000.0091,000.00https://www.sec.gov/Archives/edgar/data/1108924/000124266512000013/0001242665-12-000013-index.htm
2019-11-15David D O'TooleChief Financial OfficerBuy100.0015.001,500.009,115.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000117/0001385508-19-000117-index.htm
2019-11-26David D O'TooleChief Financial OfficerBuy100.0013.221,322.009,215.00https://www.sec.gov/Archives/edgar/data/1385508/000138550819000121/0001385508-19-000121-index.htm
2020-01-02Phil SkolnickChief Scientific OfficerSell700.0014.089,856.009,300.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000002/0001385508-20-000002-index.htm
2020-01-07Mark Jason Heath EllisonInsiderBuy4,150.009,680.00https://www.sec.gov/Archives/edgar/data/1385508/000138550820000013/0001385508-20-000013-index.htm